In 2022, there were up to 1.2 million people with HIV (PWH) and 37,981 new cases of HIV in the United States alone. 1 While ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

The study from Tulane University found that those living in once-redlined neighborhoods see 15% longer delays in achieving successful viral suppression of HIV compared to those in non-redlined areas.

“These incredibly positive outcomes offer new hope at a time when 40 million individuals worldwide are impacted by HIV and ...

The currently available ART, while highly efficacious, does not cure HIV/AIDS, highlighting the need for an effective ... The ...

“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

The article, Safety of Kidney Transplantation from Donors with HIV, details findings supporting HIV-to-HIV kidney transplants as safe and just as effective as those using organs from donors without ...

They focus on peptide nanofibrils (PNFs) on magnetic ... Researchers a Step Closer to a Cure for HIV Mar. 26, 2024 — A new study shows virus-like particle can effectively 'shock and kill' latent ...

Although sexually transmitted infections are still at an epidemic level in the US, scientists at the US Centers for Disease ...